Minerva Neuroscie (NERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,462 | 41,013 | 36,194 | 60,855 | 25,457 |
| Other current assets | 0 | 0 | 3,117 | 0 | 0 |
| TOTAL | $22,269 | $42,002 | $40,159 | $62,201 | $27,440 |
| Non-Current Assets | |||||
| PPE Net | 5 | 11 | 16 | N/A | 15,200 |
| Intangibles | 14,869 | 14,869 | 14,869 | 14,869 | 14,869 |
| Other Non-Current Assets | 0 | 17 | 43 | 51 | 117 |
| TOTAL | $14,875 | $14,897 | $14,928 | $14,921 | $30,186 |
| Total Assets | $37,144 | $56,900 | $55,087 | $77,122 | $57,626 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,608 | 1,805 | 970 | 1,853 | 996 |
| Accrued Expenses | 1,229 | 1,535 | 408 | 966 | 2,053 |
| TOTAL | $2,837 | $3,340 | $1,378 | $2,819 | $3,160 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 60,000 | 82,017 | 73,734 | 66,327 | 0 |
| TOTAL | $60,000 | $82,017 | $73,734 | $66,327 | $1,803 |
| Total Liabilities | $62,837 | $85,357 | $75,112 | $69,146 | $4,964 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,993 | 6,993 | 5,340 | 5,340 | 5,340 |
| Common Shares | 1 | 1 | 1 | 1 | 4 |
| Retained earnings | -395,377 | -396,815 | -366,810 | -334,701 | -284,795 |
| TOTAL | $-25,693 | $-28,458 | $-20,024 | $7,976 | $52,663 |
| Total Liabilities And Equity | $37,144 | $56,900 | $55,087 | $77,122 | $57,626 |